C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome
Objective: To investigate the role of C-reactive protein(CRP) level elevation and obesity for the increased cardiovasculardisease risk in polycystic ovary syndrome(PCOS).Methods: A hundred and nine patients with PCOS and 30age matched healthy volunteers with regular menstrualcycle are involved in th...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dicle University Medical School
2013-09-01
|
Series: | Dicle Medical Journal |
Subjects: | |
Online Access: | http://www.diclemedj.org/upload/sayi/28/Dicle%20Med%20J-01712.pdf |
id |
doaj-380ac0bfb5434bcca753194c3f848ce5 |
---|---|
record_format |
Article |
spelling |
doaj-380ac0bfb5434bcca753194c3f848ce52020-11-24T21:48:43ZengDicle University Medical SchoolDicle Medical Journal 1300-29451308-98892013-09-0140342643110.5798/diclemedj.0921.2013.03.0303C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndromeEda Ülkü Uludağİlay GözükaraSuna Kabil KucurHavva KeskinHalime KılıçZeynep KamalakAyşe KargılıŞenay Arıkan DurmazObjective: To investigate the role of C-reactive protein(CRP) level elevation and obesity for the increased cardiovasculardisease risk in polycystic ovary syndrome(PCOS).Methods: A hundred and nine patients with PCOS and 30age matched healthy volunteers with regular menstrualcycle are involved in the study. PCOS group is furthersubdivided into three subgroups according to the bodymass index (BMI). Subgroups included 54 with BMI<25,22 with BMI 25-30, and 33 with BMI>30. Blood samplesfor glucose, insulin, uric acid, and CRP were collected inthe morning after overnight fasting (12 hours). Homeostasismodel assessment-insulin resistance (HOMA-IR)was calculated. Results: Fasting blood glucose, insulin,and HOMA-IR was significantly higher in PCOS group(p=0.02, p=0.01 and p=0.02). CRP level was higher insubgroup with BMI>30. High CRP level in PCOS wasfound to be independent from BMI (p<0.001). HOMA-IRand insulin level was higher in the subgroup with BMI>30.When compared with the control group high insulin levelwas the only to be statistically significant in obese PCOSpatients (p=0.005). HOMA-IR was higher in PCOS subgroupwith BMI>30 when compared with controls and thePCOS subgroup with BMI<25 (p<0.001, p= 0.003).Conclusion: Obesity, hyperinsulinemia, and high CRPlevels are seemed to be related and potentiating eachother in PCOS. Struggling with obesity is one of the mostimportant issues for preventive medicine.Key words: PCOS, CRP, obesity, cardiovascular riskhttp://www.diclemedj.org/upload/sayi/28/Dicle%20Med%20J-01712.pdfPCOSCRPobesitycardiovascular risk |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eda Ülkü Uludağ İlay Gözükara Suna Kabil Kucur Havva Keskin Halime Kılıç Zeynep Kamalak Ayşe Kargılı Şenay Arıkan Durmaz |
spellingShingle |
Eda Ülkü Uludağ İlay Gözükara Suna Kabil Kucur Havva Keskin Halime Kılıç Zeynep Kamalak Ayşe Kargılı Şenay Arıkan Durmaz C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome Dicle Medical Journal PCOS CRP obesity cardiovascular risk |
author_facet |
Eda Ülkü Uludağ İlay Gözükara Suna Kabil Kucur Havva Keskin Halime Kılıç Zeynep Kamalak Ayşe Kargılı Şenay Arıkan Durmaz |
author_sort |
Eda Ülkü Uludağ |
title |
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
title_short |
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
title_full |
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
title_fullStr |
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
title_full_unstemmed |
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
title_sort |
c-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome |
publisher |
Dicle University Medical School |
series |
Dicle Medical Journal |
issn |
1300-2945 1308-9889 |
publishDate |
2013-09-01 |
description |
Objective: To investigate the role of C-reactive protein(CRP) level elevation and obesity for the increased cardiovasculardisease risk in polycystic ovary syndrome(PCOS).Methods: A hundred and nine patients with PCOS and 30age matched healthy volunteers with regular menstrualcycle are involved in the study. PCOS group is furthersubdivided into three subgroups according to the bodymass index (BMI). Subgroups included 54 with BMI<25,22 with BMI 25-30, and 33 with BMI>30. Blood samplesfor glucose, insulin, uric acid, and CRP were collected inthe morning after overnight fasting (12 hours). Homeostasismodel assessment-insulin resistance (HOMA-IR)was calculated. Results: Fasting blood glucose, insulin,and HOMA-IR was significantly higher in PCOS group(p=0.02, p=0.01 and p=0.02). CRP level was higher insubgroup with BMI>30. High CRP level in PCOS wasfound to be independent from BMI (p<0.001). HOMA-IRand insulin level was higher in the subgroup with BMI>30.When compared with the control group high insulin levelwas the only to be statistically significant in obese PCOSpatients (p=0.005). HOMA-IR was higher in PCOS subgroupwith BMI>30 when compared with controls and thePCOS subgroup with BMI<25 (p<0.001, p= 0.003).Conclusion: Obesity, hyperinsulinemia, and high CRPlevels are seemed to be related and potentiating eachother in PCOS. Struggling with obesity is one of the mostimportant issues for preventive medicine.Key words: PCOS, CRP, obesity, cardiovascular risk |
topic |
PCOS CRP obesity cardiovascular risk |
url |
http://www.diclemedj.org/upload/sayi/28/Dicle%20Med%20J-01712.pdf |
work_keys_str_mv |
AT edaulkuuludag creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT ilaygozukara creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT sunakabilkucur creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT havvakeskin creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT halimekılıc creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT zeynepkamalak creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT aysekargılı creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome AT senayarıkandurmaz creactiveproteinlevelandobesityascardiovascularriskfactorsinpolycysticovarysyndrome |
_version_ |
1725890771187400704 |